KR101408062B1 - Ｌ-아스파라기나아제 ⅱ 제조를 위한 재조합 숙주 - Google Patents

Ｌ-아스파라기나아제 ⅱ 제조를 위한 재조합 숙주 Download PDF

Info

Publication number
KR101408062B1
KR101408062B1 KR1020087028792A KR20087028792A KR101408062B1 KR 101408062 B1 KR101408062 B1 KR 101408062B1 KR 1020087028792 A KR1020087028792 A KR 1020087028792A KR 20087028792 A KR20087028792 A KR 20087028792A KR 101408062 B1 KR101408062 B1 KR 101408062B1
Authority
KR
South Korea
Prior art keywords
asparaginase
enzyme
seq
host cell
coli
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020087028792A
Other languages
English (en)
Korean (ko)
Other versions
KR20090033175A (ko
Inventor
데이비드 알. 필푸라
마오리앙 왕
Original Assignee
시그마-타우 레어 디지즈, 에스.에이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시그마-타우 레어 디지즈, 에스.에이. filed Critical 시그마-타우 레어 디지즈, 에스.에이.
Publication of KR20090033175A publication Critical patent/KR20090033175A/ko
Application granted granted Critical
Publication of KR101408062B1 publication Critical patent/KR101408062B1/ko
Assigned to 시그마-타우 파마 리미티드 reassignment 시그마-타우 파마 리미티드 권리의 전부이전등록 Assignors: 시그마-타우 레어 디지즈, 에스.에이.
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C12N9/82—Asparaginase (3.5.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020087028792A 2006-06-30 2007-06-08 Ｌ-아스파라기나아제 ⅱ 제조를 위한 재조합 숙주 Active KR101408062B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81781706P 2006-06-30 2006-06-30
US60/817,817 2006-06-30
PCT/US2007/070706 WO2008011234A2 (en) 2006-06-30 2007-06-08 Recombinant host for producing l-asparaginase ii

Publications (2)

Publication Number Publication Date
KR20090033175A KR20090033175A (ko) 2009-04-01
KR101408062B1 true KR101408062B1 (ko) 2014-06-20

Family

ID=38957454

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020087028792A Active KR101408062B1 (ko) 2006-06-30 2007-06-08 Ｌ-아스파라기나아제 ⅱ 제조를 위한 재조합 숙주

Country Status (17)

Country Link
US (2) US7807436B2 (https=)
EP (1) EP2046369B1 (https=)
JP (1) JP5308333B2 (https=)
KR (1) KR101408062B1 (https=)
CN (1) CN101484181B (https=)
AU (1) AU2007275535B2 (https=)
CA (1) CA2652718A1 (https=)
DK (1) DK2046369T3 (https=)
ES (1) ES2553329T3 (https=)
HU (1) HUE025738T2 (https=)
IL (1) IL195168A (https=)
MX (1) MX2009000284A (https=)
NZ (1) NZ572519A (https=)
PL (1) PL2046369T3 (https=)
PT (1) PT2046369E (https=)
TW (1) TWI427148B (https=)
WO (1) WO2008011234A2 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160148470A (ko) * 2015-06-15 2016-12-26 아주대학교산학협력단 재조합 미생물을 이용한 천연고무의 생산 방법
KR101837636B1 (ko) * 2016-06-14 2018-03-12 전남대학교산학협력단 코리네박테리움 재조합 균주를 이용한 아스파라기나제의 분비생산 방법

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102014000585B1 (pt) 2014-01-10 2021-01-12 Coppe/Ufrj-Instituto Alberto Luiz Coimbra De Pós-Graduação l-asparaginase recombinante de zymomonas
CN105802948B (zh) 2014-12-29 2020-06-09 江苏众红生物工程创药研究院有限公司 聚乙二醇定点修饰的门冬酰胺酶及其制备方法与应用
KR102783452B1 (ko) 2016-06-01 2025-03-19 세르비에 아이피 유케이 리미티드 폴리알킬렌 옥시드-아스파라기나제의 제형, 및 그의 제조 및 사용 방법
CN108795832B (zh) * 2017-04-26 2021-05-14 江苏恒瑞医药股份有限公司 一种内源l-门冬酰胺酶ii基因敲除的宿主菌、其制备方法及其应用
WO2019083794A1 (en) 2017-10-27 2019-05-02 Pfenex Inc. PROCESS FOR PRODUCING EAR ASPARAGINASE. RECOMBINED COLI
JP7784804B2 (ja) 2017-10-27 2025-12-12 フェネックス インク． 組み換えｅｒｗｉｎｉａアスパラギナーゼの製造のための方法
US11364223B2 (en) 2018-12-13 2022-06-21 Huyabio International, Llc Sulcardine administration for treatment of acute atrial fibrillation
US20220227805A1 (en) 2020-12-23 2022-07-21 Jazz Pharmaceuticals Ireland Ltd. Methods of purifying charge-shielded fusion proteins
CN114854729B (zh) * 2021-02-03 2025-09-02 重庆派金生物科技有限公司 定向化学偶联门冬酰胺酶突变体及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324844A (en) 1989-04-19 1994-06-28 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5122614A (en) 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
US5643575A (en) 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5919455A (en) 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
US5615460A (en) * 1994-06-06 1997-04-01 The Procter & Gamble Company Female component for refastenable fastening device having regions of differential extensibility
US6180095B1 (en) 1997-12-17 2001-01-30 Enzon, Inc. Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents
US5965119A (en) 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6958212B1 (en) 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
US7087229B2 (en) 2003-05-30 2006-08-08 Enzon Pharmaceuticals, Inc. Releasable polymeric conjugates based on aliphatic biodegradable linkers
US7122189B2 (en) 2002-08-13 2006-10-17 Enzon, Inc. Releasable polymeric conjugates based on aliphatic biodegradable linkers
CN100502944C (zh) * 2005-09-16 2009-06-24 北京双鹭药业股份有限公司 一种天门冬酰胺酶注射液、其制备方法及应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Applied Biochemistry and Biotechnology Vol.95(2):93-101 (2001) *
Applied Biochemistry and Biotechnology Vol.95(2):93-101 (2001)*
GenBank Accession # M34277 (1993. 04. 26.) *
GenBank Accession # M34277 (1993. 04. 26.)*

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160148470A (ko) * 2015-06-15 2016-12-26 아주대학교산학협력단 재조합 미생물을 이용한 천연고무의 생산 방법
KR101849238B1 (ko) 2015-06-15 2018-06-01 아주대학교산학협력단 재조합 미생물을 이용한 천연고무의 생산 방법
KR101837636B1 (ko) * 2016-06-14 2018-03-12 전남대학교산학협력단 코리네박테리움 재조합 균주를 이용한 아스파라기나제의 분비생산 방법

Also Published As

Publication number Publication date
HUE025738T2 (en) 2016-04-28
KR20090033175A (ko) 2009-04-01
MX2009000284A (es) 2009-01-26
CN101484181A (zh) 2009-07-15
WO2008011234A2 (en) 2008-01-24
ES2553329T3 (es) 2015-12-07
TW200817518A (en) 2008-04-16
IL195168A (en) 2014-12-31
PT2046369E (pt) 2015-11-26
TWI427148B (zh) 2014-02-21
JP5308333B2 (ja) 2013-10-09
US7807436B2 (en) 2010-10-05
EP2046369A4 (en) 2010-04-21
US20080063632A1 (en) 2008-03-13
CA2652718A1 (en) 2008-01-24
NZ572519A (en) 2011-06-30
DK2046369T3 (en) 2015-11-30
AU2007275535B2 (en) 2012-08-16
CN101484181B (zh) 2012-12-26
AU2007275535A1 (en) 2008-01-24
JP2009542219A (ja) 2009-12-03
IL195168A0 (en) 2011-08-01
US20100273236A1 (en) 2010-10-28
EP2046369A2 (en) 2009-04-15
PL2046369T3 (pl) 2016-01-29
WO2008011234A3 (en) 2008-10-16
EP2046369B1 (en) 2015-08-12

Similar Documents

Publication Publication Date Title
KR101408062B1 (ko) Ｌ-아스파라기나아제 ⅱ 제조를 위한 재조합 숙주
US5916793A (en) Arginine deiminase derived from Mycoplasma arthritidis and polymer conjugates containing the same
CN101432296B (zh) 聚乙二醇化的突变的肉毒梭菌毒素
KR102139844B1 (ko) 암 표적화 치료용 알부민-결합 아르기닌 데이미나제를 포함하는 약제학적 조성물
EP0856059A1 (en) Methods for production of recombinant plasmids
US11021690B2 (en) Mutant-type uricase, PEG modified mutant-type uricase, and application thereof
JP2010500963A (ja) 安定化タンパク質
EP0931093A1 (en) Helicobacter pylori live vaccine
KR102000490B1 (ko) 가용성이 개선된 살모넬라균 편모 유래 플라젤린 단백질 발현 형질전환체, 그 제조방법 및 용도
KR101658081B1 (ko) CysQ를 융합파트너로 이용한 재조합 단백질의 제조방법
RU2803949C1 (ru) Способ экспрессии белка crm197
KR101658082B1 (ko) Eda를 융합파트너로 이용한 재조합 단백질의 제조방법
HK40101360A (zh) 用於癌症、肥胖症、代谢紊乱和相关并发症及合并症的精氨酸耗竭剂的组合物和应用
HK1128929B (en) Pegylated mutated clostridium botulinum toxin

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20081125

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20110527

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20120524

Comment text: Request for Examination of Application

N231 Notification of change of applicant
PN2301 Change of applicant

Patent event date: 20121108

Comment text: Notification of Change of Applicant

Patent event code: PN23011R01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20131031

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20140422

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20140610

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20140611

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20170530

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20170530

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20180601

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20180601

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20190902

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20190902

Start annual number: 6

End annual number: 6

PR1001 Payment of annual fee

Payment date: 20210610

Start annual number: 8

End annual number: 8

PR1001 Payment of annual fee

Payment date: 20230608

Start annual number: 10

End annual number: 10

PR1001 Payment of annual fee

Payment date: 20240610

Start annual number: 11

End annual number: 11